threonine has been researched along with apigenin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Li, AG; Li, HH; Liu, X; Sheppard, HM | 1 |
| Cai, X; Liu, X | 1 |
3 other study(ies) available for threonine and apigenin
| Article | Year |
|---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression.
Topics: Alanine; Amino Acid Substitution; Antineoplastic Agents; Apigenin; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Damage; Drug Stability; Flavonoids; G1 Phase; Histone Acetyltransferases; Humans; Nuclear Proteins; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; TATA-Binding Protein Associated Factors; Threonine; Transcription Factor TFIID; Transfection; Tumor Suppressor Protein p53 | 2004 |
Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apigenin; Cell Line, Tumor; Cell Nucleus; Cytoplasm; DNA Damage; Etoposide; Exportin 1 Protein; Humans; Karyopherins; Models, Biological; Neuroblastoma; Phosphorylation; Proto-Oncogene Proteins c-mdm2; Receptors, Cytoplasmic and Nuclear; Threonine; Tumor Suppressor Protein p53 | 2008 |